Results 191 to 200 of about 173,083 (299)

Muscle bursting and corticomotor excitability mark impaired impulse control in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Warden ACM, McAllister CJ, Cruse D, Wright B, MacDonald HJ.   +4 more
europepmc   +1 more source

Surprise Marketing

Psychology &Marketing, EarlyView.
ABSTRACT Surprise marketing, characterized by unexpected tactics such as blind boxes and spontaneous discounts, captivates consumers by sparking curiosity and participation. Despite increasing industry use, scholarly research remains fragmented and limited.
Xin‐Jean Lim, Weng Marc Lim, Park Thaichon   +2 more
wiley   +1 more source

Pharmacological management of childhood constipation: Bridging today's gaps with tomorrow's therapies. [PDF]

World J Clin Pediatr
Rajindrajith S, Hathagoda W, Balakrishnan K, Devanarayana NM.   +3 more
europepmc   +1 more source

The Order to Treat: Judicial Intervention in Benign Neglect of Defective Infants [PDF]

, 1982
Guerrini, Marianne E., Horan, Dennis J.
core   +1 more source

Evaluating the Role of α‐Synuclein Seed Amplification as a Disease Progression Marker: Evidence and Uncertainties

Movement Disorders Clinical Practice, EarlyView.
Abstract Background α‐synuclein seeding amplification assay (α‐synuclein SAA) development as a diagnostic biomarker for Parkinson's disease (PD) has shown promising results over the past decade. However, the utility of these assays in the prediction of disease progression is unclear.
Daniel Belete, Christian Mattjie, Brook Huxford, Jonathan P. Bestwick, Alastair J. Noyce, Cristina Simonet   +5 more
wiley   +1 more source

Determinants of ICU Admission Care Limitation in Patients Younger Than 65 Years: A Prospective, Observational, Multicenter Study. [PDF]

Crit Care Explor
Guillon E, Jonas M, Rieul G, Reizine F, Fedun Y, Delbove A.   +5 more
europepmc   +1 more source

Automating Subthalamic Deep Brain Stimulation Programming with Evoked Resonant Neural Activity in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Optimal outcomes from subthalamic nucleus deep brain stimulation (STN‐DBS) for Parkinson's disease (PD) depend on accurate stimulation of an ideal functional target within the dorsolateral STN. Clinical programming is heuristic, and objective methods are needed to improve efficiency and consistency.
Kanae J. Nagao, Thushara Perera, Matthew Petoe, Wee‐Lih Lee, San San Xu, Kiaran Lawson, Ashton Moorhead, Hugh McDermott, Kristian Bulluss, Wesley Thevathasan   +9 more
wiley   +1 more source

Beyond Glycemia: Pharmacology-Driven Ketogenesis and Euglycemic DKA with SGLT2 Inhibitors-A Practical Review for Acute Care. [PDF]

J Pers Med
Meco M, Agosteo E, Zulli P, Nisi F, Giustiniano E.   +4 more
europepmc   +1 more source

Issues in Health Care Meriting Particular Christian Concern - A Priority Issue: The Severely Defective Newborn [PDF]

, 1982
Roy, David
core   +1 more source

Speech and Deep Brain Stimulation in Parkinson's Disease, Essential Tremor, and Dystonia: A Systematic Review and Meta‐analysis

Movement Disorders, EarlyView.
Abstract Deep brain stimulation (DBS) effectively treats motor symptoms in movement disorders but often compromises speech through incompletely defined mechanisms. We conducted a PROSPERO‐registered systematic review and meta‐analysis of publications through August 2024 (CRD42024527738).
Elina Tripoliti, Takashi Tsuboi, Michael T. Barbe, Mario Sousa, Julie Barkmeier‐Kraemer, Hannah Jergas, Gaia Arno, Nicole Buie, Mikayla Day, Petr Krýže, Jayson R. Nelson, Aaron E.L. Warren, Shervin Rahimpour, Jan Rusz, Paul Krack, Kristina Simonyan   +15 more
wiley   +1 more source